| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 57,125,273 | 59,191,432 | 52,339,333 | | Cost of Revenue | 30,085,817 | 30,279,878 | 26,528,788 | | | Gross Profit | 27,039,456 | 28,911,554 | 25,810,545 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 13,799,553 | 21,186,194 | 19,540,440 | | Non Recurring | 1,788,909 |
-
| (14,523) | | Others | 1,347,673 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 10,103,320 | 7,725,361 | 6,284,628 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 351,015 | (89,847) | (109,585) | | Earnings Before Interest And Taxes | 10,763,060 | 7,635,514 | 6,175,043 | | Interest Expense | 713,308 |
-
| 778,977 | | Income Before Tax | 10,049,751 | 7,635,514 | 5,396,066 | | Income Tax Expense | 2,599,487 | 1,661,431 | 1,513,064 | | Minority Interest |
-
|
-
| (356,481) | | | | Net Income From Continuing Ops | 7,450,265 | 5,974,082 | 3,677,036 | | | Non-recurring Events | | Discontinued Operations |
-
| 117,832 | 1,755,999 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 7,450,265 | 6,091,914 | 5,433,035 | | Preferred Stock And Other Adjustments |
-
| (365,279) |
-
| | | Net Income Applicable To Common Shares | $7,450,265 | $5,726,635 | $5,433,035 |
|
0.22% Nasdaq 
0.08 (0.25%) 
Income Statement
